Literature DB >> 24828683

A validation of the new definition of drug-resistant epilepsy by the International League Against Epilepsy.

Jose F Téllez-Zenteno1, Lizbeth Hernández-Ronquillo, Samantha Buckley, Ricardo Zahagun, Syed Rizvi.   

Abstract

OBJECTIVE: To establish applicability, the recently proposed International League Against Epilepsy (ILAE) consensus on drug-resistant epilepsy (DRE) requires testing in clinical and research settings. This study evaluates the reliability and validity of these criteria in a clinical population.
METHODS: In phase I, two independent evaluators reviewed 97 randomly selected medical records of patients with epilepsy at two separate intervals. Both ILEA consensus and standard diagnostic criteria were employed. Kappa, weighted kappa, and intraclass correlation coefficient (ICC) were used to determine interobserver and intraobserver variability. In phase II, ILAE consensus criteria were applied to 250 patients with epilepsy to determine risk factors associated with development of DRE and to calculate point prevalence.
RESULTS: The interobserver agreement of the four definitions was as follows: Berg (0.56), Kwan and Brodie (0.58), Camfield and Camfield (0.69), and ILAE (0.77). The intraobserver agreement of the four definition was as follows: Berg (0.81), Kwan and Brodie (0.82), Camfield and Camfield (0.72), and ILAE (0.82). The prevalence of DRE was the following: with the Berg's definition was 28.4%, Kwan and Brodie 34%, Camfield and Camfield 37%, and with ILAE was 33%. SIGNIFICANCE: This is first study to establish reliability and validity of ILAE criteria for the diagnosis of DRE. This new definition compares favorably with previously established constructs, which continue to retain clinical significance. Wiley Periodicals, Inc.
© 2014 International League Against Epilepsy.

Entities:  

Keywords:  Consensus; Drug-resistant epilepsy; Reliability; Validation; Validity

Mesh:

Substances:

Year:  2014        PMID: 24828683     DOI: 10.1111/epi.12633

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  27 in total

1.  Consensus Over Individualism: Validation of the ILAE Definition for Drug Resistant Epilepsy.

Authors:  Barbara C Jobst
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  Computer-assisted planning for the insertion of stereoelectroencephalography electrodes for the investigation of drug-resistant focal epilepsy: an external validation study.

Authors:  Vejay N Vakharia; Rachel Sparks; Roman Rodionov; Sjoerd B Vos; Christian Dorfer; Jonathan Miller; Daniel Nilsson; Martin Tisdall; Stefan Wolfsberger; Andrew W McEvoy; Anna Miserocchi; Gavin P Winston; Aidan G O'Keeffe; Sebastien Ourselin; John S Duncan
Journal:  J Neurosurg       Date:  2018-04-01       Impact factor: 5.115

Review 3.  Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Authors:  John A Lawson; Ingrid E Scheffer
Journal:  Br J Clin Pharmacol       Date:  2018-09-05       Impact factor: 4.335

Review 4.  Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.

Authors:  Martin J Brodie
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

5.  Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.

Authors:  Jesse Elliott; Sasha van Katwyk; Bláthnaid McCoy; Tammy Clifford; Beth K Potter; Becky Skidmore; George A Wells; Doug Coyle
Journal:  Pharmacoeconomics       Date:  2019-10       Impact factor: 4.981

6.  Comparison of fiber tract low frequency stimulation to focal and ANT stimulation in an acute rat model of focal cortical seizures.

Authors:  Nicholas H Couturier; Dominique M Durand
Journal:  Brain Stimul       Date:  2019-12-28       Impact factor: 8.955

Review 7.  Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review.

Authors:  Wanlin Lai; Dan Du; Lei Chen
Journal:  Neurochem Res       Date:  2022-01-24       Impact factor: 3.996

8.  International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy.

Authors:  Heidrun Potschka; Andrea Fischer; Wolfgang Löscher; Ned Patterson; Sofie Bhatti; Mette Berendt; Luisa De Risio; Robyn Farquhar; Sam Long; Paul Mandigers; Kaspar Matiasek; Karen Muñana; Akos Pakozdy; Jacques Penderis; Simon Platt; Michael Podell; Clare Rusbridge; Veronika Stein; Andrea Tipold; Holger A Volk
Journal:  BMC Vet Res       Date:  2015-08-28       Impact factor: 2.741

9.  2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs.

Authors:  M Podell; H A Volk; M Berendt; W Löscher; K Muñana; E E Patterson; S R Platt
Journal:  J Vet Intern Med       Date:  2016-02-22       Impact factor: 3.333

Review 10.  Overview of Nrf2 as Therapeutic Target in Epilepsy.

Authors:  Liliana Carmona-Aparicio; Claudia Pérez-Cruz; Cecilia Zavala-Tecuapetla; Leticia Granados-Rojas; Liliana Rivera-Espinosa; Hortencia Montesinos-Correa; Jacqueline Hernández-Damián; José Pedraza-Chaverri; Aristides Sampieri; Elvia Coballase-Urrutia; Noemí Cárdenas-Rodríguez
Journal:  Int J Mol Sci       Date:  2015-08-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.